Sir Codelot writes: A hacker who calls himself Kirllos has obtained and is now offering to sell 1.5 million Facebook IDs at astonishingly low prices — $25 per 1000 IDs for users with fewer than 10 friends and $45 per 1000 IDs for users with more than 10 friends. Looking at the numbers, Kirllos has stolen the IDs of one out of every 300 Facebook users.
An anonymous reader writes: Google accused of YouTube 'free ride'. Telefonica, France Telecom and Deutsche Telekom all said Google should start paying them for carrying bandwidth-hungry content such as YouTube video over their networks.
An anonymous reader writes: The University of Southampton is the proud owner of one of the world's most powerful supercomputers which academics are using to recreate ancient archaelogical sites, simulate the effects of medicine on humans and design airplanes of the future. Interestign stuff...
from the watch-what-you-say-and-everybody-else-too dept.
An anonymous reader writes "The Indian Supreme Court has ruled that bloggers cannot shelter under an escape clause such as 'Any views expressed are solely those of the writers' to exercise freedom of speech in discussions and statements online. The ruling comes in response to an anti-defamation case filed against a 19 year old student's Orkut community, commenting upon the right-wing political organization Shiv Sena. This organization is based in the western state of Maharashtra and has been responsible for inflammatory speeches and numerous attacks upon non-Maharashtrians." The article does not make it entirely clear whether the student owner is himself accused of defamatory speech, or only commenters posting on his site. His defense that an Orkut community is not equivalent to a public forum was denied.
from the one-antibody-to-rule-them-all dept.
Plasmoid writes "The NYTimes is reporting that scientists have starting developing what could turn out to be a 'universal' flu vaccine. They created antibody proteins that can neutralize different strains of the influenza virus, including the deadly H5N1 bird flu, the virus behind the 1918 epidemic, and common seasonal strains. These new antibodies target part of the virus that is shared between different strains and thus appear to be broadly effective. However, some experts question whether a universal vaccine of this kind is even possible, since the human body has been unable to come up with an antibody solution. An article on nature.com describes the work further."